CANCER DIAGNOSTICS

“Cancer is a genetic disease.
A few gene mutations can transform a normal cell into a malignant cancer cell.”

HAI YAN

CHIEF SCIENTIST, GENETRON

Genetron Health's oncology platform covers multiple cancers—key capabilities include detecting unique gene mutations, classifying tumors, predicting and evaluating disease development, assisting patients in selecting targeted drugs and chemotherapeutics, evaluating the efficacy of immunotherapy, monitoring drug resistance and other diseases, as well as assisting in the formulation of personalized clinical diagnostics and treatment plans.

...

FULL CYCLE CANCER CARE

CANCER DIAGNOSTICS & MONITORING   ------------------------------------------------------------------------------------------------------------------------

2,305,656DAYS

LIFE EXTENDED FOR
PATIENTS OF A SINGLE
CANCER TYPE IN CHINA

TUMOR TYPES

LUNG
BRAIN
LIVER
COLON
STOMACH
THYROID
BREAST
BLADDER

COMPREHENSIVE MOLECULAR
DIAGNOSTIC SOLUTIONS

01

IN-VITRO DIAGNOSTICS

Precision diagnostics uses methods in molecular biology to detect changes in the structure or expression of genetic material in organisms to produce a diagnosis. Genetron's IVD platform provides solutions for molecular diagnosis using core fluorescent quantitative PCR, digital PCR, and high-throughput sequencing (NGS) systems.

02

LABORATORY DEVELOPED TEST

Genetron Health LDT products can be more comprehensive coverage of the solid tumor related genes and provide both tissue biopsy and liquid biopsy. The products play the roles from a single-gene first-generation sequencing to the small and medium-sized panel centered on targeted therapy and typing prognosis of a certain cancer type, and to the large panel recommended by the comprehensive diagnosis and treatments for pan-cancer based on NGS technology. Meanwhile, the products can provide customized testing services for the cooperations with drug R & D clinical trials.